Brazil resumes clinical trials of Chinese coronavirus vaccine Sinovac

Brazil's health regulator Anvisa on Wednesday (local time) announced the resumption of clinical trials of China's Sinovac COVID-19 vaccine. Quoting the latest official statement issued by Anvisa, Anadolu agency's said, "After evaluating the new data presented by the sponsor ... Anvisa understands that it has sufficient reasons to allow the resumption of vaccination."

from IndiaTV World: Google News Feed https://ift.tt/36wEZp7